Alethea Capital Management, LLC Top Holdings and 13F Report (2025) About Alethea Capital Management, LLCInvestment ActivityAlethea Capital Management, LLC has $134.03 million in total holdings as of March 31, 2025.Alethea Capital Management, LLC owns shares of 11 different stocks, but just 3 companies or ETFs make up 80% of its holdings.Approximately 7.26% of the portfolio was purchased this quarter.About 11.29% of the portfolio was sold this quarter.This quarter, Alethea Capital Management, LLC has purchased 30 new stocks and bought additional shares in 3 stocks.Alethea Capital Management, LLC sold shares of 1 stock and completely divested from 20 stocks this quarter.Largest Holdings Axsome Therapeutics $77,835,130SPDR Bloomberg 1-3 Month T-Bill ETF $28,073,239Avidity Biosciences $12,449,292SPDR S&P 500 ETF Trust $8,374,068Kura Oncology $4,350,568 Largest New Holdings this Quarter 78462F103 - SPDR S&P 500 ETF Trust $8,374,068 Holding Largest Purchases this Quarter SPDR S&P 500 ETF Trust 14,970 shares (about $8.37M)SPDR Bloomberg 1-3 Month T-Bill ETF 7,290 shares (about $668.71K)Kura Oncology 100,735 shares (about $664.85K)Avidity Biosciences 853 shares (about $25.18K) Largest Sales this Quarter Axsome Therapeutics 66,949 shares (about $7.81M) Sector Allocation Over TimeMap of 500 Largest Holdings ofAlethea Capital Management, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAXSMAxsome Therapeutics$77,835,130$7,808,262 ▼-9.1%667,36858.1%MedicalBILSPDR Bloomberg 1-3 Month T-Bill ETF$28,073,239$668,712 ▲2.4%306,04220.9%ETFRNAAvidity Biosciences$12,449,292$25,181 ▲0.2%421,7249.3%MedicalSPYSPDR S&P 500 ETF Trust$8,374,068$8,374,068 ▲New Holding14,9706.2%FinanceKURAKura Oncology$4,350,568$664,851 ▲18.0%659,1773.2%MedicalTLTiShares 20+ Year Treasury Bond ETF$2,104,8870.0%23,1231.6%ETFHEDJWisdomTree Europe Hedged Equity Fund$376,2790.0%7,9250.3%FinanceCIDARA THERAPEUTICS INC$308,2590.0%14,3110.2%COM NEWEVMEaton Vance California Municipal Bond Fund$98,8000.0%10,6580.1%Financial ServicesLPROOpen Lending$33,1200.0%12,0000.0%FinanceTGBTaseko Mines$22,4000.0%10,0000.0%Basic MaterialsCFGCitizens Financial Group$0$461,055 ▼-100.0%00.0%FinanceMOAltria Group$0$437,458 ▼-100.0%00.0%Consumer StaplesAMTAmerican Tower$0$428,629 ▼-100.0%00.0%FinanceHPQHP$0$401,447 ▼-100.0%00.0%Computer and TechnologyPNWPinnacle West Capital$0$399,775 ▼-100.0%00.0%UtilitiesDUKDuke Energy$0$394,544 ▼-100.0%00.0%UtilitiesSWKSSkyworks Solutions$0$394,271 ▼-100.0%00.0%Computer and TechnologyPFEPfizer$0$393,440 ▼-100.0%00.0%MedicalFANGDiamondback Energy$0$392,373 ▼-100.0%00.0%EnergyINVHInvitation Homes$0$391,505 ▼-100.0%00.0%FinanceAPAAPA$0$384,956 ▼-100.0%00.0%EnergyDGDollar General$0$383,649 ▼-100.0%00.0%Retail/WholesaleMRKMerck & Co., Inc.$0$369,867 ▼-100.0%00.0%MedicalTHE CAMPBELLS COMPANY$0$369,088 ▼-100.0%00.0%COMAMGNAmgen$0$346,651 ▼-100.0%00.0%MedicalVLOValero Energy$0$314,566 ▼-100.0%00.0%EnergyIRMIron Mountain$0$303,137 ▼-100.0%00.0%Business ServicesDVNDevon Energy$0$273,852 ▼-100.0%00.0%EnergyVTRVentas$0$265,888 ▼-100.0%00.0%FinanceESSEssex Property Trust$0$217,791 ▼-100.0%00.0%FinanceShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
